Effect of Ursolic Acid on Anti-tumor and Intestinal Bacterial Community Structure and Diversity in H22 Tumor-bearing Mice
-
摘要: 研究熊果酸对H22荷瘤小鼠抗肿瘤及肠道细菌的影响。皮下接种H22肝癌细胞构建移植瘤小鼠模型，设正常组、模型组、阳性对照组（环磷酰胺）和熊果酸组（低、中、高剂量），连续给药3周后，计算抑瘤率和肝脾指数，检测血清T淋巴细胞亚群、白细胞介素-2（IL-2）和肿瘤坏死因子α（TNF-α）浓度，采用高通量测序技术分析熊果酸对H22荷瘤肠道细菌群落结构多样性的影响。结果显示，与模型组相比，熊果酸各剂量组均能显著减少移植瘤质量（P<0.05），其中熊果酸中、高剂量组能显著提高荷瘤小鼠血清中T细胞亚群、IL-2和TNF-α的含量（P<0.05）。主成分分析（Principal Component Analysis，PCA）显示，与正常组比较，模型组和熊果酸低剂量组小鼠肠道细菌相似性差异显著（P<0.05），而熊果酸中剂量组和高剂量组小鼠肠道细菌相似性差异不显著（P>0.05）。熊果酸各剂量组肠道细菌在门水平和科水平的比例和分布均比模型组更接近正常组。与模型组比较，熊果酸小鼠肠道Akkermansia和Lactobacillus丰度显著增加（P<0.05），而Muribaculum显著减少（P<0.05）。表明熊果酸可抑制肿瘤生长，增强H22荷瘤小鼠免疫力，对肿瘤小鼠肠道细菌菌群紊乱具有一定恢复作用。Abstract: The purpose of this study was to investigate the effect of ursolic acid(UA)on anti-tumor and intestinal bacteria in H22 tumor-bearing mice. In this experiment,the models of tumor-bearing mice were established by injection of colonic cancer cells H22. Then,the mice were randomly divided into normal group,model group,positive control group(cytoxan group)and the groups treated with low,middle and high dose of UA,respectively. After 3 weeks,the tumor inhibition rate,index of liver and spleen were calculated. The concentrations of T-cell subsets,interleukin-2(IL-2)and tumor necrosis factorα(TNF-α)in serum were detected. The effect of ursolic acid on intestinal bacterial community structure and diversity in H22 tumor-bearing mice were analyzed using high-throughput sequencing platform. The results showed that UA could significantly reduce the xenograft tumor weight compared with the model group(P<0.05). The level of T-cell subsets,IL-2 and TNF-α in mice treated with middle and high dose of UA significantly increased by comparing with the model group(P<0.05). Compared with normal group,PCA analysis indicated that there were significantly differences in intestinal bacteria of model group and group treated with low dose of UA. However,there were no significant difference in intestinal bacteria of groups treated with middle and high dose of UA by comparing with normal group(P>0.05). At phylum and family level,the proportion and distribution of intestinal bacteria in mice treated with UA were closer to the normal group than model group. Compared with model group,the relative abundance of Akkermansia and Lactobacillus significantly increased in mice treated with UA(P<0.05),and the relative abundance of Muribaculum significantly decreased(P<0.05). It indicated that UA could inhibit the growth of tumor and increase immunity of mice,accelerate the recovery of intestinal bacteria imbalance associated with tumor.
-
Keywords:
- ursolic acid /
- anti-tumor /
- intestinal bacteria /
- immune function
-
[1] 李超,金莉萍. 肠道细菌与癌症关系的研究进展[J]. 微生物与感染,2018,13(6):379-386. [2] Martel C,Georges D,Bray F,et al. Global burden of cancer attributable to infections in 2018:A worldwide incidence analysis[J]. The Lancet Global Health,2020,8(2):1-18.
[3] Quigley E M. Gut microbiome as a clinical tool in gastrointestinal disease management:are we there yet?[J]. Nature Reviews Gastroenterology and Hepatology,2017,14(5):315-320.
[4] Dapito D H,Mencin A,Gwak G Y,et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J]. Cancer Cell,2012,21(4):504-516.
[5] Huang X P,Wang W C. Chemical constituents of Ligustrum lucidum fruits:research advances[J]. Journal of International Pharmaceutical Research,2011,38(1):47-51.
[6] Kottke T,Jill T,Diaz L,et al. Subversion of NK-cell and TNF-α immune surveillance drives tumor recurrence[J]. Cancer Immunology Research,2017,5(11):1029-1045.
[7] 姚宏斌,梁惠,刘颖,等. 熊果酸对小鼠H22移植瘤的抑制作用研究[J]. 癌变·畸变·突变,2013,25(1):1-6. [8] Walters W,Hyde E R,Berg L D,et al. Improved bacterial 16s rRNA gene(V4 and V4-5)and fungal internal transcribed spacer marker gene primers for microbial community surveys[J]. Msystems,2017,1(1):9-15.
[9] Bolyen E,Rideout J R,Dillon M R et al. Reproducible,interactive,scalable and extensible microbiome data science using QⅡME2[J]. Nature Biotechnology,2019,37(9):1091.
[10] 钟金凤,方热军. 环磷酰胺免疫抑制机制及在动物模型上的应用[J]. 中国免疫学杂志,2016,32(10):1541-1546. [11] 李莉,陆小凡,赵焕英,等. 干性记忆型T细胞及其在抗肿瘤研究中的进展[J]. 中国老年学杂志,2018,38(18):4574-4576. [12] 李艳红,李晓波,陆雪莹,等. 熊果酸对H22荷瘤小鼠抗肿瘤及免疫调节作用[J]. 实验动物科学,2013,30(5):1-5. [13] 冯馨锐,崔雨舒,何志涛,等. 肿瘤坏死因子-α的生物学功能研究进展[J]. 吉林医药学院学报,2019,40(1):66-68. [14] 方学辉,吴倩,韩雪梅,等. 熊果酸抗小鼠H22肝癌移植瘤及对免疫功能的影响[J]. 肿瘤学杂志,2013,19(3):199-201. [15] Lkirk J,Beaudette L,Miranda H,et al. Methods of studying soil microbial diversity[J]. Journal of Microbiological Methods,2004,58(2):169-188.
[16] 甄宏德,王爱国,钱祥,等. 原发性肝癌H-ras12V小鼠肠道微生态的初步研究[J]. 中国微生态学杂志,2018,30(2):132-136. [17] Garrett W S. Cancer and the microbiota[J]. Science,2015,384(6230):6-20.
[18] Ruth E,Peter J. Samuel K,et al. Human gut microbes associated with obesity[J]. Nature,2006,444(7122):1022-1023
[19] Ren Z,Li A,Jiang J W,et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma[J]. Gut,2019,68(7):1014-1023.
[20] Zitvogel L,Galluzzi L,Viaud S,et al. Cancer and the gut microbiota:An unexpected link[J]. Science Translational Medicine,2015,7(271):271.
[21] Tropini C,Moss EL,Merrill B D,et al. Transient osmotic perturbation causes long-term alteration to the gut microbiota[J].Cell,2018,173(7):1742-1754.
[22] 胡亚欣,余蕾,刘华娟,等. 急性肝衰竭小鼠肠道微生态的变化[J]. 中华肝脏病杂志,2017,25(4):291-296. [23] 谢园,陈玲霞,刘雨霞,等. 肠道菌群在宿主抗柠檬酸杆菌感染中的作用和机制[J]. 赣南医学院学报,2019,39(10):973-978. [24] Giorgia G. How gut microbes are joining the fight against cancer[J]. Nature,2018,557(7706):482-484.
[25] RoutyB,Chatelier E,Derosa L,et al. Gut microbiome influences efficacy of Pd-1-based immunotherapy against epithelial tumors[J]. Science,2018,359(637):91-97.
[26] 李慧臻,李柏良,李子叶,等. 乳酸杆菌抗肿瘤作用的研究进展[J]. 食品工业科技,2018,40(2):336-341. [27] Adeshirlarijaney A,Gewirtz AT. Considering gut microbiota in treatment of type 2 diabetes mellitus[J]. Gut Microbes,2020,31(3):253-264.
[28] 刘程鹏,刘丽坤,周琪,等. 组方食品对2型糖尿病小鼠血糖及肠道菌群的影响[J]. 中国微生态学杂志,2018,3(7):781-784. [29] 张圣方,赵龙玉,赵凤春,等. 泰山蛹虫草多糖对免疫抑制小鼠肠道菌群及分泌型免疫球蛋白A的影响[J]. 食品科学,2015,36(5):148-152. [30] Daillere R,Vetizou M,Waldschmitt N,et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects[J]. Immunity,2016,45(4):931-943.
[31] 王鹏,张忠义,吴忠. 熊果酸在药用植物中的分布及药理作用[J]. 中药材,2000,20(11):717-722.
计量
- 文章访问数:
- HTML全文浏览量:
- PDF下载量:
下载:
